Stock·NYSE·Financial Services
American Express Company (AXP)
- Market cap
- $218.54B
- P/E
- 19.20
- Dividend yield
- 1.13%
- Street target
- $370.00median of 30 analysts
- 52-week range
- $290.97 $387.49
The short version
Where AXP stands today, and what CleaRank Financial AI makes of it.
AXP at a glance
American Express Company (AXP): Buy, 63/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($320.18 and $327.92).
- Earnings AXP beat estimates in 7 of its last 8 quarters, yet fell the next day after 5 of those beats.
- Insiders Insiders sold $158.1M and made no open-market purchases over the last 18 months.
- Valuation P/E of 19.2 against 16.5 for the Financial Services sector: broadly in line with peers (+16%).
Figures as of October 22, 2026.
CleaRank Financial AI
CleaRank rates American Express Company (AXP) Buy, with a model score of 63/100.
The analysts' outlook lifts the score most: 16 of 30 analysts rate it a buy and the median target is 14.3% above the price. The trend holds it back most: the price is 1.31% below its 200-day average, and the 50-day average is 2.36% below the 200-day. The 50-day average stands at $320.18 and the 200-day at $327.92. Over the past year the price fell 8.90%.
Only on CleaRank
Figures we compute ourselves from AXP's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $323.61 is 1.1% above the 50-day simple moving average of $320.18.Price above its 200-day average ›
The price is 1.3% below the 200-day simple moving average of $327.92.50-day average above the 200-day ›
The 50-day average ($320.18) is 2.4% below the 200-day average ($327.92), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 34% of its 52-week range, between $290.97 and $387.49.
AXP share price
Pick a period: each tab shows how far AXP has moved over it, to the last close.
Today's trading
Where AXP sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 19.20 is 16.4% above the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 3.01 is 20.7% below the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $11.3B on revenue of $70.9B, a net margin of 16.0%.Beat estimates in most recent reports ›
AXP beat the EPS estimate in 7 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 1.13%, or $3.67 a share a year.
Key statistics
The headline figures for AXP.
As of October 22, 2026, AXP trades at $323.61, with a market value of $218.54B, a P/E ratio of 19.20 and a dividend yield of 1.13%.
What the numbers say
CleaRank Financial AI's reading of AXP's valuation, growth and risks.
American Express Company (AXP) carries a trailing P/E of 19.20, which is 16.4% above the Financial Services median of 16.5. The peer comparison on this page calls that broadly in line with peers. Measured on sales, the P/S of 3.01 sits 20.8% below the sector median of 3.8. Its market value stands at $218.5B.
In the latest quarter, against the same quarter a year earlier, revenue grew 12.80%, 1.1 percentage points faster than the sector median of 11.7%. AXP turns sales into profit at a net margin of 16.14% and an operating margin of 20.32%, alongside a return on equity of 34.38%, above the sector median of 13.8%. Debt-to-equity of 1.72 and a trailing dividend yield of 1.13% ($3.67 a share a year) round out the fundamentals.
Expectations were topped in the July 24, 2026 report, with EPS of $4.53 coming in 2.95% ahead of the $4.40 estimate. In the first session after the release, the share price climbed 2.83%.
AXP has beaten the EPS estimate in 7 of its last 8 reports, yet the share price fell in the next session after 5 of those 7 beats. Analysts forecast EPS of $17.64 for this fiscal year, a rise of 14.7%, and $20.13 for the year after, a rise of 14.1%.
AXP's daily returns have a 30-day standard deviation of 1.22%, and its beta against the S&P 500 is 1.09. At present the price is 16.49% under its 52-week high of $387.49. Insiders sold $158.1M of stock over the last 18 months and bought none on the open market. Sales like these are often scheduled ahead of time or made to pay tax on vesting shares, so they carry less weight than purchases would.
AXP against the Financial Services sector
How AXP compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (16% difference), suggesting fair market pricing relative to industry standards.
Return vs XLF: Since May 9, 2025, AXP has gained 13.7% against a gain of 12.5% for XLF.
Performance against XLF
AXP and the Financial Services sector fund over the same days.
Revenue and earnings
How much AXP sells, and how much of it becomes profit.
Revenue growth: Revenue grew 9.5% in FY2025 to $72.2B, from $65.9B a year earlier.
Profit margin: The net margin was 15.0% in FY2025, down from 15.4% the year before.
Profitable: AXP earned $10.8B in FY2025.
Earnings reality check
Did AXP beat what analysts expected, and how did the stock react?
Earnings record: AXP beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 5 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 24, 2026after close | $4.40 | $4.53 | +2.95% | +2.83% | +3.09% |
| Apr 23, 2026after close | $3.99 | $4.28 | +7.27% | -1.40% | +1.41% |
| Jan 30, 2026after close | $3.55 | $3.53 | -0.56% | +0.19% | +1.98% |
| Oct 17, 2025after close | $3.98 | $4.14 | +4.02% | +0.83% | +3.16% |
| Jul 18, 2025after close | $3.88 | $4.08 | +5.15% | -1.62% | +1.19% |
| Apr 17, 2025after close | $3.47 | $3.64 | +4.90% | -3.50% | +5.37% |
| Jan 24, 2025after close | $3.03 | $3.04 | +0.33% | -1.53% | -1.21% |
| Oct 18, 2024after close | $3.29 | $3.49 | +6.08% | -2.19% | -3.41% |
As of October 22, 2026, AXP has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 5 of those beats; its latest report, on July 24, 2026, came in 2.95% above the estimate and the stock moved +2.83% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 63.8, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 63.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of AXP
The score, the reasoning behind it, and what could move the price next.
American Express Company (AXP) is caught between its two moving averages. Its price of $323.61 is 1.31% below the 200-day average of $327.92, yet 1.07% above the 50-day average of $320.18. Because the averages trail the price, the 50-day sits 2.36% below the 200-day. Within the 52-week range of $290.97 to $387.49, the stock currently stands at 34% of the way up.
Recent gains sit against a weaker longer record: the price rose 3.20% over the past month, fell 7.21% over the past three months and fell 8.90% over the past year. On momentum, the 14-day RSI reads 63.8, in the bullish zone, below the overbought line, although the MACD line is negative, which pulls the other way.
Earnings beat ›
The July 24, 2026 report beat the EPS estimate by 2.95%, and the share price rose 2.83% in the first session after it.
Source: Earnings report, July 24, 2026Rating reaffirmed ›
Morgan Stanley kept its Equal-Weight rating on October 12, 2026.
Source: Analyst action, Morgan Stanley, October 12, 2026
New analyst coverage ›
BMO Capital started coverage at Outperform on October 9, 2026.
Source: Analyst action, BMO Capital, October 9, 2026
- Keep an eye on the two nearest levels: the 200-day SMA at $327.92 sits above the price, and the 50-day SMA at $320.18 sits below it.
- The 14-day RSI reads 63.8, in the bullish zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price rose 2.83% in the first session after the July 24, 2026 report. Over the last 8 reports, AXP beat estimates in 7 of them.
The trend is mixed: AXP is above its 50-day average at $320.18 but below its 200-day average at $327.92. A close above the 200-day would turn both signals up, and a close below the 50-day would turn both down. In the meantime the price sits between the 50-day SMA ($320.18) underneath and the 200-day SMA ($327.92) overhead.
Momentum is firmly in the bullish band on the RSI, a reading that backs the current direction while stopping short of looking overstretched.
Technical indicators
Momentum and trend for AXP, from its daily closes.
As of October 22, 2026, with AXP at $323.61, its 14-day RSI is 63.8 (showing bullish momentum without being overbought), its 50-day simple moving average is $320.18 and its 200-day is $327.92.
Calculated by CleaRank on daily closes as of October 22, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What AXP moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 22, 2026, AXP's 1-year correlation of daily returns is +0.68 with S&P 500 (SPY), +0.55 with Nasdaq 100 (QQQ), +0.27 with Bitcoin (BTC) and +0.02 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
16 of 30 analysts rate it a buy or strong buy, 14 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $370.00 is 14.3% above the price.More buy ratings than three months ago ›
16 of 30 rate it a buy now, against 15 of 30 three months ago.
AXP Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Oct 12, 2026 | JP Morgan | Maintains | Overweight |
| Oct 9, 2026 | RBC Capital | Maintains | Outperform |
| Oct 9, 2026 | BMO Capital | Initiates | Outperform |
| Oct 6, 2026 | TD Cowen | Maintains | Hold |
| Oct 5, 2026 | UBS | Maintains | Neutral |
As of October 22, 2026, 30 Wall Street analysts cover AXP: 16 rate it a buy or strong buy, 14 a hold and 0 a sell or strong sell. Their 12-month price targets range from $320.00 to $450.00, with a median of $370.00, 14.3% above the price of $323.61.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AXP trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from AXP's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AXP tends to move, against the market and on its own.
The long record
AXP's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.22% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 43.6%, from February 2020 to March 2020, regained by February 2021.Most 1-year holds ended higher ›
78% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $55,205, against $42,099 in the S&P 500 (SPY).
AXP Drawdowns & Recovery
As of October 22, 2026, AXP's worst peak-to-trough fall over the last 10 years with dividends reinvested was -43.6% (February 2020 to March 2020); it regained that peak by February 2021, 11 months after the low, and 78% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AXP in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: AXP beat the S&P 500 over this period: $55,205 against $42,099.
A $10,000 investment in AXP in October 2016 would be worth about $55,205 today with dividends reinvested, compared with about $42,099 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AXP, and which have not.
Strongest month, November: an average of +7.46%, up in 8 of 10 years.
Weakest month, March: an average of -4.04%, up in 3 of 10 years.
This month, October: has averaged +1.09%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, AXP's strongest calendar month has been November (average +7.46%, up in 8 of 10 years) and its weakest March (average -4.04%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AXP, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in AXP today could grow to about $25,233 by 2036 in the base case, with a 90th-percentile outcome near $90,463 and a 10th-percentile outcome around $7,038. The simulation models price only; at today's 1.13% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
AXP Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $469 for AXP by 2030 in the base case, from $324 today (1.4x over 4 years). The 10th-percentile path ends near $209. These are outcomes of a Monte Carlo simulation run on AXP's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $237 | $355 | $532 | |
| 2028 | $220 | $389 | $689 | |
| 2029 | $212 | $427 | $860 | |
| 2030 | $209 | $469 | $1,051 | |
| 2031 | $208 | $514 | $1,268 |
Method: a lognormal simulation of AXP's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
AXP insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought AXP shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 22, 2026, AXP insiders reported 24 open-market sales worth $158.1M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | Monique Herena
Officer
|
Sell | 8.8K | $3.0M |
| Jun 15, 2026 | Glenda G Mcneal
Officer
|
Sell | 7.0K | $2.4M |
| Mar 13, 2026 | Raymond D Joabar
Officer
|
Sell | 40 | $12.3K |
| Mar 6, 2026 | Quinn Jessica Lieberman
Officer
|
Sell | 3.0K | $909.7K |
| Feb 19, 2026 | Raymond D Joabar
Officer
|
Sell | 14.0K | $4.8M |
| Feb 12, 2026 | Howard M Grosfield
Officer
|
Sell | 8.1K | $2.8M |
| Feb 9, 2026 | Ravikumar S Radhakrishnan
Chief Technology Officer
|
Sell | 15.0K | $5.3M |
| Feb 9, 2026 | Laureen E Seeger
Officer
|
Sell | 12.7K | $4.6M |
| Feb 5, 2026 | Anna Marrs
Officer
|
Sell | 27.4K | $9.6M |
| Feb 5, 2026 | Denise Pickett
Officer
|
Sell | 23.4K | $8.3M |
| Feb 5, 2026 | Anna Marrs
Officer
|
Option | 15.0K | $2.6M |
| Feb 5, 2026 | Denise Pickett
Officer
|
Option | 12.7K | $2.2M |
| Jan 30, 2026 | Douglas E Buckminster
Officer
|
Grant | 39.9K | - |
| Jan 30, 2026 | Howard M Grosfield
Officer
|
Grant | 17.3K | - |
| Jan 30, 2026 | Monique Herena
Officer
|
Grant | 18.8K | - |
| Jan 30, 2026 | Raymond D Joabar
Officer
|
Grant | 24.3K | - |
| Jan 30, 2026 | Caillec Christophe Le
Chief Financial Officer
|
Grant | 17.3K | - |
| Jan 30, 2026 | Quinn Jessica Lieberman
Officer
|
Grant | 5.9K | - |
| Jan 30, 2026 | Rafael Marquez
Officer
|
Grant | 17.3K | - |
| Jan 30, 2026 | Anna Marrs
Officer
|
Grant | 26.9K | - |
| Jan 30, 2026 | Glenda G Mcneal
Officer
|
Grant | 11.8K | - |
| Jan 30, 2026 | Denise Pickett
Officer
|
Grant | 21.0K | - |
| Jan 30, 2026 | Ravikumar S Radhakrishnan
Chief Technology Officer
|
Grant | 20.2K | - |
| Jan 30, 2026 | Elizabeth Rutledge
Officer
|
Grant | 9.1K | - |
| Jan 30, 2026 | Laureen E Seeger
Officer
|
Grant | 27.1K | - |
| Jan 30, 2026 | Jennifer Skyler
Officer
|
Grant | 10.0K | - |
| Jan 30, 2026 | Stephen J Squeri
Chief Executive Officer
|
Grant | 123.0K | - |
| Jan 30, 2026 | Douglas J Tabish
Officer
|
Grant | 9.5K | - |
| Dec 12, 2025 | Raymond D Joabar
Officer
|
Sell | 1.4K | $538.9K |
| Dec 12, 2025 | Raymond D Joabar
Officer
|
Grant | 650 | - |
| Dec 4, 2025 | Douglas E Buckminster
Officer
|
Grant | 13.8K | - |
| Oct 31, 2025 | Elizabeth Rutledge
Officer
|
Sell | 50.0K | $18.0M |
| Oct 31, 2025 | Elizabeth Rutledge
Officer
|
Option | 50.0K | $3.3M |
| Oct 23, 2025 | Douglas J Tabish
Officer
|
Sell | 2.5K | $894.4K |
| Oct 22, 2025 | Denise Pickett
Officer
|
Sell | 5.0K | $1.8M |
| Oct 21, 2025 | Stephen J Squeri
Chief Executive Officer
|
Grant | 28.1K | - |
| Sep 4, 2025 | Stephen J Squeri
Chief Executive Officer
|
Sell | 112.3K | $37.0M |
| Sep 4, 2025 | Stephen J Squeri
Chief Executive Officer
|
Option | 112.3K | $14.8M |
| Sep 3, 2025 | Monique Herena
Officer
|
Sell | 8.7K | $2.8M |
| Sep 3, 2025 | Monique Herena
Officer
|
Grant | 610 | - |
| Sep 2, 2025 | Douglas E Buckminster
Officer
|
Sell | 23.5K | $7.7M |
| Sep 2, 2025 | Douglas E Buckminster
Officer
|
Grant | 610 | - |
| Sep 2, 2025 | Douglas E Buckminster
Officer
|
Option | 23.5K | $1.3M |
| Aug 6, 2025 | Laureen E Seeger
Officer
|
Sell | 78.7K | $23.4M |
| Aug 6, 2025 | Laureen E Seeger
Officer
|
Option | 17.0K | $3.0M |
| Jul 29, 2025 | Glenda G Mcneal
Officer
|
Sell | 50.0K | $15.5M |
| Jul 29, 2025 | Anna Marrs
Officer
|
Sell | 5.5K | $1.7M |
| Jul 29, 2025 | Glenda G Mcneal
Officer
|
Option | 50.0K | $3.3M |
| May 20, 2025 | Rafael Marquez
Officer
|
Sell | 12.0K | $3.6M |
| May 13, 2025 | Raymond Joabar
Officer
|
Sell | 400 | $121.0K |
| May 6, 2025 | Howard M Grosfield
Officer
|
Sell | 9.5K | $2.6M |
| Apr 29, 2025 | Glenda G Mcneal
Officer
|
Sell | 3.0K | $799.0K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 22, 2026.